These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1233 related articles for article (PubMed ID: 9204896)
1. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896 [TBL] [Abstract][Full Text] [Related]
2. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469 [TBL] [Abstract][Full Text] [Related]
4. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279 [TBL] [Abstract][Full Text] [Related]
5. Signaling vascular morphogenesis and maintenance. Hanahan D Science; 1997 Jul; 277(5322):48-50. PubMed ID: 9229772 [No Abstract] [Full Text] [Related]
7. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Otani A; Takagi H; Oh H; Koyama S; Matsumura M; Honda Y Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1912-20. PubMed ID: 10440243 [TBL] [Abstract][Full Text] [Related]
8. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Mandriota SJ; Pepper MS Circ Res; 1998 Oct; 83(8):852-9. PubMed ID: 9776732 [TBL] [Abstract][Full Text] [Related]
9. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723 [TBL] [Abstract][Full Text] [Related]
10. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis. Veikkola T; Alitalo K Dev Cell; 2002 Sep; 3(3):302-4. PubMed ID: 12361591 [TBL] [Abstract][Full Text] [Related]
11. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2. Abbott BD; Buckalew AR Dev Dyn; 2000 Dec; 219(4):526-38. PubMed ID: 11084652 [TBL] [Abstract][Full Text] [Related]
12. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. Witzenbichler B; Maisonpierre PC; Jones P; Yancopoulos GD; Isner JM J Biol Chem; 1998 Jul; 273(29):18514-21. PubMed ID: 9660821 [TBL] [Abstract][Full Text] [Related]
13. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955 [TBL] [Abstract][Full Text] [Related]
14. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Yu Y; Varughese J; Brown LF; Mulliken JB; Bischoff J Am J Pathol; 2001 Dec; 159(6):2271-80. PubMed ID: 11733376 [TBL] [Abstract][Full Text] [Related]
15. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K Oncology; 2002; 62(4):340-8. PubMed ID: 12138242 [TBL] [Abstract][Full Text] [Related]
16. The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis. Kim I; Moon SO; Han CY; Pak YK; Moon SK; Kim JJ; Koh GY Cardiovasc Res; 2001 Mar; 49(4):872-81. PubMed ID: 11230987 [TBL] [Abstract][Full Text] [Related]
17. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia. Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Otani A; Takagi H; Oh H; Koyama S; Honda Y Diabetes; 2001 Apr; 50(4):867-75. PubMed ID: 11289054 [TBL] [Abstract][Full Text] [Related]
19. Expression and hypoxic regulation of angiopoietins in human astrocytomas. Ding H; Roncari L; Wu X; Lau N; Shannon P; Nagy A; Guha A Neuro Oncol; 2001 Jan; 3(1):1-10. PubMed ID: 11305411 [TBL] [Abstract][Full Text] [Related]
20. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Yuan HT; Khankin EV; Karumanchi SA; Parikh SM Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]